<DOC>
	<DOCNO>NCT02130505</DOCNO>
	<brief_summary>In study , investigate inflammatory system healthy volunteer patient T2DM insulin therapy hyperlipidemia ( familial hyperlipidemia ( FH ) familial combine hyperlipidemia ( FCH ) ) OGTT .</brief_summary>
	<brief_title>Inflammatory Aspects Glucose Hyperlipidemia Diabetes</brief_title>
	<detailed_description>Cardiovascular disease ( CVD ) number one killer Netherlands . Insulin resistance dyslipideima main cause CVD . Recently , show acute leukocyte activation oral glucose tolerance test ( OGTT ) patient newly-diagnosed diabets mellitus type 2 ( T2DM ) . Leukocyte activation important obligatory aspect process atherosclerosis . Complement system another important inflammatory component atherosclerosis , becomes activate postprandial phase . In study , investigate inflammatory system healthy volunteer patient T2DM insulin therapy hyperlipidemia ( familial hyperlipidemia ( FH ) familial combine hyperlipidemia ( FCH ) ) OGTT .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hyperlipidemia , Familial Combined</mesh_term>
	<criteria>Provide write informed consent Aged 4565 year BMI &lt; 35 kg/m2 Emotionally intellectually capable decide participation study consequence participation . Subjects able understand patient information Diabetes mellitus treat oral antidiabetic medicine Type 1 diabetes mellitus Peripheral artery and/or coronary disease Untreated hypertension Alcohol use &gt; 2 units/day Aberrations kidney , liver thyroid function Use experimental medication within 6 month study The use immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>